Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2021 - 06/30/2021

Lobbyist name	Jennifer A Herz
Business name	Boehringer Ingelheim Pharmaceuticals, Inc.
Address	900 Ridgebury Road
City, state, zip code	Ridgefield, CT 06877
Country	US
Agent type	Both
Phone	860-970-4404

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Boehringer Ingelheim Pharmaceuticals, Inc.

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	1123	An Act relative to pharmaceutical gag clauses	Neutral	$92.00	N/A
House Bill	1991	An Act relative to fairness in worker’s compensation disfigurement benefits	Neutral	$92.00	N/A
House Bill	1157	An Act relative to transparent health care data	Neutral	$92.00	N/A
House Bill	729	An Act to ensure prescription drug cost transparency and affordability	Oppose	$92.00	N/A
Senate Bill	70	An Act further defining eligibility for medical use marijuana	Oppose	$92.00	N/A
House Bill	1053	An Act relative to consumer deductibles	Oppose	$92.00	N/A
House Bill	201	An Act advancing health care research and decision-making centered on patients and people with disabilities	Neutral	$92.00	N/A
House Bill	115	An Act relative to best management practices for wireless in schools and public institutions of higher education	Neutral	$92.00	N/A
Senate Bill	786	An Act to bring down the cost of prescription drugs	Neutral	$92.00	N/A
Senate Bill	771	An Act relative to pharmaceutical access, costs and transparency	Neutral	$92.00	N/A
House Bill	1190	An Act relating to patient cost, benefit, and coverage information, choice, and price transparency	Oppose	$92.00	N/A
			Total amount	$1,012.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.